搜索历史清除全部记录
- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
About Us
Zhejiang Tianxian Biopharmaceutical Co., Ltd.
Established on January 20, 2022, Zhejiang Tianxian Biopharmaceutical Co., Ltd. is located in the scenic Yangfu Industrial Park in Xianju, Taizhou, Zhejiang Province. It is a joint venture company spearheaded by Zhejiang Xianju Pharmaceutical Co., Ltd., integrating industry resources and professional technical teams. The company primarily focuses on the research, development, production, and sales of high-end biopharmaceutical products and high-end sterile active pharmaceutical ingredients.
The company's management team mainly consists of members from pharmaceutical companies, with an average of over 15 years of industry experience and an average age of under 40. This experienced and dynamic management team forms the foundation for the company's standardized management and long-term development. The company adheres to technological innovation as its driving force, pursuing sustainable development, focusing on non-steroidal high-end sterile active pharmaceutical ingredients and biomedicine. It integrates product research, development, production, processing, and sales to establish a complete product system, striving to become a high-tech, multi-faceted company covering the pharmaceutical, beauty, food, and cosmetics industries.
The company's main products are sodium hyaluronate, with applications covering food, cosmetics, medical devices, and pharmaceuticals. The company is committed to using its unique technology and processes to produce high-quality products, with a focus on high-end sterile hyaluronic acid. In addition to its own R&D products, the company maintains close collaborations with universities, research institutes, and R&D companies. In the future, the company will focus more on biomedicine, new drug synthesis processes, and sterile active pharmaceutical ingredients.
The company is currently under construction and will have a production capacity exceeding 200 tons upon completion. Simultaneously, the company has initiated the construction of its pharmaceutical quality management system and product registration, aiming to complete product registration with China NMPA, US FDA, and European EDQM by 2025 and obtain relevant GMP certifications.
As a new biopharmaceutical manufacturing enterprise, we firmly believe that professionalism and hard work can create greater value. Our vision is to become a high-quality international pharmaceutical company. Adhering to an open, learning, and collaborative work attitude, we strive to become a guardian of human health.
Company Culture
Openness
Focus
Innovation
Cooperation
Honors and Qualifications